On the value of the activated clotting time for monitoring heparin therapy in acute coronary syndromes.
Melandri
G
G
Institute of Cardiology, University of Bologna, Polyclinic S. Orsola, Italy.
Branzi
A
A
Traini
A M
AM
Semprini
F
F
Cervi
V
V
Magnani
B
B
D000789:Angina, Unstable / Q000188:drug therapy* / Q000453:epidemiology; D003325:Coronary Care Units; D005069:Evaluation Studies as Topic; D005260:Female; D006493:Heparin / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D008991:Monitoring, Physiologic / Q000379:methods*; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000453:epidemiology; D010314:Partial Thromboplastin Time; D011446:Prospective Studies; D012008:Recurrence; D015912:Thrombolytic Therapy; D014914:Whole Blood Coagulation Time
D006493:Heparin